News – Page 37 – Endpoints News

Protagonist, Takeda's profit sharing deal under spotlight after Phase 3 blood disorder trial win

3 months ago

Novartis licenses Kyorin’s preclinical chronic hives candidate for $55M upfront

3 months ago

Genentech's TNKase gets new approval; Sanofi gives up rights to oncology candidate

3 months ago

Novo Nordisk signs $354M partnership with AI-guided biotech for ‘risky’ new metabolic mechanisms

3 months ago

ADCs from a decade-old Singapore biotech find new life with $187M

3 months ago

After Phase 3 depression setback, Neumora pauses two trials to make changes, scraps another

3 months ago

ICER finds GSK inhalers offer advantages over generic competitors

3 months ago

Lexicon plots Phase 3 trial for diabetic pain drug despite mid-stage flop

3 months ago

AbbVie finally enters obesity race with $350M upfront for Gubra’s amylin

3 months ago

The top 100 biotech investors; FDA vaccine meeting canceled; Can Bill Anderson save Bayer?; and more

3 months ago

At least eight drugmakers say they will participate in round two of IRA negotiations

3 months ago

Bipartisan 'pill penalty' fix and other bills vie for inclusion in reconciliation package

3 months ago

CHMP recommends Regeneron, Novartis drugs that still await FDA approval

3 months ago

Exclusive: Infectious disease doctors consider 'mini-ACIP' if RFK erodes CDC vaccine panel

3 months ago

Praxis says its essential tremor drug failed a Phase 3 readout, but plans to complete study

3 months ago

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai and CRISPR Therapeutics

3 months ago

BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen

3 months ago

Pfizer vet William Pao’s next venture; Sanofi’s computational science exec leaves

3 months ago

Trump’s science crackdown hits rare disease research: ‘We need to sit down with Elon Musk’

3 months ago

Lilly joins molecular glue field with Magnet deal worth up to $1.25B

3 months ago

CDC is investigating five hospitalizations after use of Valneva’s chikungunya vaccine

3 months ago

HHS’ vaccine injury panel in limbo after monthlong meeting delay

3 months ago

Pharma-backed Mission Therapeutics stops preclinical operations, focuses on two clinical assets

3 months ago

Drug policy veteran at CMS to depart on Friday

3 months ago

First page Previous page 34 35 363738 39 40 Next page Last page